摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-chloro-1-methyl-6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one | 54748-06-0

中文名称
——
中文别名
——
英文名称
8-chloro-1-methyl-6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one
英文别名
RL 214;8-chloro-1-methyl-6-phenyl-4,6-dihydro-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-5-one;8-chloro-4,6-dihydro-1-methyl-6-phenyl-5H-S-triazolo[4,5-a][1,5]benzodiazepin-5-one;8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one;1-Methyl-8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,5]-benzodiazepin-5-one;1-methyl-8-chloro-6-phenyl-4H-s-triazolo-[4,3-a][1,5]benzodiazepin-5-one;8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-one
8-chloro-1-methyl-6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one化学式
CAS
54748-06-0
化学式
C17H13ClN4O
mdl
——
分子量
324.769
InChiKey
XVMDIBGSCXIXJJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    297-298 °C(Solv: ethanol (64-17-5))
  • 沸点:
    648.0±65.0 °C(Predicted)
  • 密度:
    1.41±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    51
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    8-chloro-1-methyl-6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one劳森试剂氢氧化钾苄基三乙基氯化铵对甲苯磺酸 作用下, 以 氯苯甲苯 为溶剂, 反应 48.5h, 生成 (8-Chloro-1-methyl-6-phenyl-6H-2,3,6,10b-tetraaza-benzo[e]azulen-5-yl)-dimethyl-amine
    参考文献:
    名称:
    1,5-Benzodiazepines XI. 5-(Dialkylamino) or 5-(alkylthio) substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines with anticonvulsant activity
    摘要:
    The cyclocondensation of (dimethylamino)benzodiazepinones 3a,b with hydrazides yielded triazolobenzodiazepinones 4 which were treated with Lawesson's reagent to give thiolactams 5. The phase-transfer catalyzed (TEBA) alkylation of compounds 5 with suitable alkyl halides afforded 5-(alkylthio)-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines 6a-f. The desired N,N-dialkyl-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines 7a-k were finally obtained from the reaction of the (methylthio)derivatives 6a-d with proper dialkylamines. Compounds 6b-f and 7a-e, g-k were screened for anticonvulsant activity after a preliminary evaluation of their gross behavioral effects and acute toxicity. Nine of the 15 triazolobenzodiazepines tested exerted a clear-cut anticonvulsant effect associated with low acute toxicity. In particular, the most active compounds 6e, f and 7h showed LD50/ED50 ratios that were notably higher than that of phenobarbital and ranging from 50% to 20% of that of diazepam, the latter used as reference drugs.
    DOI:
    10.1016/0223-5234(93)90088-v
  • 作为产物:
    参考文献:
    名称:
    1,5-Benzodiazepin-4-ones
    摘要:
    本文披露了一种1,5-苯并二氮平-4-酮衍生物,其在1,2-位置之间带有三唑环。这些1,2-三唑基-1,5-苯并二氮平-4-酮可用作肌肉松弛剂、抗惊厥和镇静剂。
    公开号:
    US04111934A1
点击查看最新优质反应信息

文献信息

  • 4H-s-triazolo[4,3-a][1,5]benzodiazepin-5-ones
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04164498A1
    公开(公告)日:1979-08-14
    Compounds of the following formula ##STR1## are useful as central nervous system depressants, tranquilizers, sedatives, growth promotors, anti-convulsants and muscle relaxants in mammalian species.
    以下公式##STR1##的化合物在哺乳动物中作为中枢神经系统抑制剂、镇静剂、安眠药、生长促进剂、抗惊厥剂和肌肉松弛剂方面具有用途。
  • 4H-s-Triazolo[4,3-a][1,5]benzodiazepin-5-ones as tranquilizers
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04164580A1
    公开(公告)日:1979-08-14
    Compounds of the following formula ##STR1## are useful as central nervous system depressants, tranquilizers, sedatives, growth promotors, anti-convulsants and muscle relaxants in mammalian species.
    以下化学式的化合物##STR1##在哺乳动物中可用作中枢神经系统抑制剂、镇静剂、安眠药、生长促进剂、抗惊厥药和肌肉松弛剂。
  • Novel 4H-S-triazolo[4,3-A] [1,5]benzodiazepin-5-ones
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04213982A1
    公开(公告)日:1980-07-22
    Compounds of the following formula ##STR1## are useful as central nervous system depressants, tranquilizers, sedatives, growth promotors, anti-convulsants and muscle relaxants in mammalian species.
    以下公式的化合物##STR1##在哺乳动物物种中可用作中枢神经系统抑制剂、镇静剂、催眠剂、生长促进剂、抗痉挛剂和肌肉松弛剂。
  • S-triazolo-1,5-benzodiazpine-4-ones
    申请人:The Upjohn Company
    公开号:US04075202A1
    公开(公告)日:1978-02-21
    A s-triazolo-1,5-benzodiazepin-4-one selected from the group of compounds of the formulae: ##STR1## wherein R.sub.o is hydrogen, alkyl of 1 to 3 carbon atoms, inclusive, hydroxy, hydroxymethyl, and ##STR2## in which R" and R'" are hydrogen or alkyl defined as above, or together ##STR3## is selected from the group consisting of pyrrolidino, piperidino, morpholino, and N-methylpiperazino; wherein R is hydrogen, alkyl of 1 to 3 carbon atoms, inclusive and ##STR4## in which R" and R'" are hydrogen or alkyl as defined above or together ##STR5## is defined as above; wherein R.sub.1 is hydrogen or methyl; wherein R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are selected from the group consisting of hydrogen, alkyl alkyl defined as above, halogen, nitro, trifluoromethyl, and alkylthio in which alkyl is defined as above are produced from the corresponding 4-hydrazino-2H-1,5-benzodiazepines-2-ones of the formula (11A) ##STR6## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5 have the significance of above, with an acetic acid chloride or if R.sub.o is hydrogen with ethyl ortho-formate, and heating to an elevated temperature to give the corresponding 4H-s-triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one which by additional procedures can be converted to the various compounds presented by formula 111A. Compounds of formula 111B are best obtained by reacting a 4-thio-1H-1,5-benzodiazepine-2,4-(3H,5H)-dione (1A) ##STR7## with a selected carbazate, followed by heating to an elevated level. Additional steps are necessary to synthesize the various compounds presented by formula 111B. The new compounds of formula 111A and 111B have tranquilizing and sedative activity.
    从下列式中选择一种s-三唑并[1,5]苯二氮平-4-酮化合物:##STR1##其中R.sub.o为氢、1至3个碳原子的烷基、羟基、羟甲基和##STR2##其中R"和R'"为氢或上述定义的烷基,或者一起##STR3##从吡咯烷基、哌啶基、吗啉基和N-甲基哌嗪基中选择;其中R为氢、1至3个碳原子的烷基和##STR4##其中R"和R'"为上述定义的氢或烷基,或者一起##STR5##如上所述定义;其中R.sub.1为氢或甲基;其中R.sub.2、R.sub.3、R.sub.4和R.sub.5从氢、上述定义的烷基、卤素、硝基、三氟甲基和硫代烷基中选择,其中烷基如上所述,由相应的式(11A)的4-肼基-2H-1,5-苯并二氮平-2-酮##STR6##其中R.sub.1、R.sub.2、R.sub.3、R.sub.4和R.sub.5具有上述意义,与乙酸氯或如果R.sub.o为氢,则与乙酸乙酯酸酐反应,并加热至高温,以得到相应的4H-s-三唑并[4,3-a][1,5]苯并二氮平-5(6H)-酮,通过其他步骤可以将其转化为公式111A所示的各种化合物。公式111B的化合物最好是通过将4-硫代-1H-1,5-苯并二氮平-2,4-(3H,5H)-二酮(1A)##STR7##与选择的卡巴肼反应,然后加热至高温来获得的。需要其他步骤来合成公式111B所示的各种化合物。公式111A和111B的新化合物具有镇静和催眠作用。
  • 4H-S-Triazolo[4,3-2][1,5]benzodiazepin-5-ones
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04133809A1
    公开(公告)日:1979-01-09
    Compounds of the following formula ##STR1## are useful as central nervous system depressants, tranquilizers, sedatives, growth promotors, anti-convulsants and muscle relaxants in mammalian species.
    以下化合物的公式##STR1##在哺乳动物物种中作为中枢神经系统抑制剂、镇静剂、安眠药、促进生长剂、抗惊厥剂和肌肉松弛剂是有用的。
查看更多

同类化合物

叔-丁基3-(羟甲基)-7,8-二氢-4H-[1,2,3]三唑并[1,5-A][1,4]二氮杂卓-5(6H)-甲酸基酯 乙基4-(4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)哌嗪-1-羧酸酯 9H-[1,2,4]三唑并[4,3-a][1,4]二氮杂卓 9-氯-5,6-二氢-4-甲基-1-(2-噻吩基)-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 9-氯-1-(2-呋喃基)-5,6-二氢-4-甲基-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-5-(4-甲基哌嗪-1-基)-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓 2-[(8-氯-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)硫烷基]-N,N-二甲基乙胺 2-[(8-氯-1-甲基-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓-5-基)硫基]-N,N-二甲基乙胺 1H-环丙并[d][1,2,4]三唑并[4,3-b]哒嗪 1H,5H-[1,2,4]三唑并[1,2-a][1,2]二氮杂卓-1,3,5(2H)-三酮,6,9-二氢-2,7-二甲基-9-(2-吡啶基)- (9ci)-1H-1,2,4-噻唑并[4,3-c][1,3]二氮杂卓 (9ci)-1H-1,2,4-噻唑并[4,3-a][1,4]二氮杂卓 ethyl 1,5-di(4-chlorophenyl)-4a-methyl-3a-phenyl-3a,4a,8,13-tetrahydro-4H-[1,2,4]oxadiazolo[5,4-d][1,2,4]triazolo[4,3-a][1,5]benzodiazepine-7-carboxylate ethyl 1-(4-chlorophenyl)-4a-methyl-5-(4-nitrophenyl)-3a-phenyl-3a,4a,8,13-tetrahydro-4H-[1,2,4]oxadiazolo[5,4-d][1,2,4]triazolo[4,3-a][1,5]benzodiazepine-7-carboxylate ethyl 3,7-di(4-chlorophenyl)-3a-methyl-4a,5-diphenyl-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate ethyl 7-(4-chlorophenyl)-3a-methyl-3-(4-nitrophenyl)-4a,5-diphenyl-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate 5,6-Dihydro-6-(4-nitrobenzoyl)-4H-[1,2,4]triazolo-[4,3-a][1,5]benzodiazepin 6,7-dibromo-9-[(diethylamino)acetyl]-3H-pyrido[3,2-c]-s-triazolo-[4,3-a][1,5]benzodiazepin-3-one 3-(trifluoromethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine 1-ethoxycarbonyl-3a-methyl-3-(4-tolyl)-5-phenyl-3,3a,4,11-tetrahydro-<1,2,4>triazolo<4,3-a><1,5> benzodiazepine aminomethyl-7,8-dihydro-4H-[1,2,3]triazolo[1,5-a][1,4]diazepine-5(6H)-carboxylic acid tert-butyl ester ethyl 3a-methyl-3-(4-nitrophenyl)-4a,5-diphenyl-7-(4-tolyl)-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate diethyl trans-3a-methyl-4a-phenyl-3,5-bis(p-nitrophenyl)-3a,4,4a,5-tetrahydro-3H-bis<1,2,4>triazolo<4,3-a:3',4'-d><1,5>benzodiazepine-1,7-dicarboxylate diethyl cis-3a-methyl-4a-phenyl-3,5-bis(p-nitrophenyl)-3a,4,4a,5-tetrahydro-3H-bis<1,2,4>triazolo<4,3-a:3',4'-d><1,5>benzodiazepine-1,7-dicarboxylate ethyl 3-(4-chlorophenyl)-3a-methyl-4a,5-diphenyl-7-(4-tolyl)-3a,4a,8,13-tetrahydro-4H-bis-[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate 1-ethoxycarbonyl-3a-methyl-3,5-diphenyl-3,3a,4,11-tetrahydro-<1,2,4>triazolo<4,3-a><1,5> benzodiazepine 4-hydro-5-phenyl-1H-s-triazolo<4,3-a><1,5>benzodiazepin-1-one 2,4-dihydro-5-phenyl-1H-s-triazolo<4,3-a><1,5>benzodiazepin-1-one 4-hydro-2-methyl-5-phenyl-1H-s-triazolo<4,3-a><1,5>benzodiazepin-1-one Dimethyl-1,7 ditriazolo<4,3-a;3,4-d>benzodiazepine-1,5 1-Methyl-5-piperidin-1-yl-4H-2,3,6,10b-tetraaza-benzo[e]azulene 1-Methyl-5-(4-methyl-piperazin-1-yl)-4H-2,3,6,10b-tetraaza-benzo[e]azulene 4-(1-Methyl-4H-2,3,6,10b-tetraaza-benzo[e]azulen-5-yl)-piperazine-1-carboxylic acid ethyl ester 8-Chloro-5-oxo-5,6-dihydro-4H-1,2,6,10b-tetraaza-benzo[e]azulene-3-carboxylic acid ethyl ester (1S,2R,8S,9R)-5-methyl-3,5,7-triazatetracyclo[7.2.1.02,8.03,7]dodec-10-ene-4,6-dione (1S,2S,8R,9R)-5-methyl-3,5,7-triazatetracyclo[7.2.1.02,8.03,7]dodec-10-ene-4,6-dione N,N-diethyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5-amine 9H-bis<1,2,4>triazolo<4,3-a:3',4'-d><1,5>benzodiazepine N,N-dimethyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepin-5-amine 4H-<1,2,4>-triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one 1-cyclohexyl-5,6-dihydro-4-(1H-indazol-3-ylmethyl)-5-oxo-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine-6-acetic acid N,N-Dipropyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amine 1,4-Dimethyl-5,6-dihydro-4H-2,3,6,10b-tetraaza-benzo[e]azulene 2-methyl-hexahydro-6-oxa-2,3a,7c-triaza-4,4e-cyclo-cyclopenta[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-1,3-dione r-10a,t-11a-dimethyl-5,6,10,10a,11,11a-hexahydro-1,3,8,10-tetraphenyl-1H-bis<1,2,4>triazolo<4,3-d:3',4'-g><1,4>diazepine 4-(2-Dimethylaminoethyl)-1-methyl-8-chloro-6-phenyl-4H-s-triazolo[4,3-a] [1,5]benzodiazepin-5-one 3a,5,5-Trimethyl-1,3-diphenyl-3a,4,5,6-tetrahydro-3H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepine (R)-8-bromo-1,4-dimethyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 9-chloro-4-methyl-1-naphthalen-2-yl-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine